News
🇺🇸 FDA Page 56Latest pharmaceutical news, drug approvals, and FDA regulatory updates
Showing 661–672 of 807 articles
UCB Acquires Neurona Therapeutics for NRTX-1001 Epilepsy Cell Therapy in $XXX Million Deal
Epilepsy · 3 min
Dr. Sarah MitchellXodus Medical Receives FDA 510(K) Clearance for Hot Pink Pad Surgical Temperature Management System
FDA · 2 min
James Chen, PharmDargenx VYVGART Shows Promise Across Multiple Myasthenia Gravis Subtypes in New AAN 2026 Clinical Data
3 min
James Chen, PharmDNuvalent's Zidesamtinib Shows Promise in ROS1-Positive Lung Cancer Patients at AACR 2026
2 min
Dr. Sarah MitchellFDA Approves Verapamil: Cardio-Med’s Extended-Release Formulation for Hypertension
FDA · hypertension · 8 min
Dr. Sarah MitchellFDA Approves IMGN-901: Breakthrough Therapy for Relapsed/Refractory AML
FDA · Acute Myeloid Leukemia · 4 min
Dr. Sarah MitchellFDA Approves Revitan Gene Therapy for SMA Type 3: Key Details
FDA · Spinal Muscular Atrophy · 4 min
Dr. Sarah MitchellFDA Approval Mito-X: Accelerated Approval for Advanced Mitochondrial Disease
FDA · Mitochondrial Disease · 8 min
Dr. Sarah MitchellFDA Approves Xylocor: Novel Therapy for Refractory Angina
FDA · Cardiology · 4 min
Dr. Sarah MitchellMAIA Biotechnology Activates First U.S. Site for Phase 2 Telomere-Targeting NSCLC Treatment Trial
2 min
James Chen, PharmDDr. Falk Pharma and Renexxion Announce Naronapride Phase 2b Gastroparesis Results at DDW 2026
2 min
Dr. Sarah MitchellLilly's Foundayo Shows 57% Mortality Reduction in Landmark ACHIEVE-4 Diabetes Trial
Type 2 Diabetes with Cardiovascular Benefits · 3 min
James Chen, PharmDPopular topics
- Drug Approvals 1,128 articles
- Clinical Trials 634 articles
- Regulatory Updates 687 articles
- FDA News 502 articles
- Press Releases 443 articles
- Oncology 443 articles
- Rare Diseases 141 articles
Explore intelligence
- Global markets Cross-region command center
- Company directory Sponsor & marketer profiles
- Drug profiles INN & regulatory status
- Clinical trials hub Stage & therapy filters
- Pipeline programs R&D intelligence
- Patent landscape US & EP IP moats
- Event calendar Congress catalysts
- Regulatory reference Submission types & pathways